Project Details
Description
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 (ASP9785) vs. Bicalutamide in Castrate Men with Metastatic Prostate Cancer
Status | Finished |
---|---|
Effective start/end date | 2/27/12 → 7/20/15 |
Funding
- ASTELLAS PHARMA US, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.